Other languages CV Sciences, Inc.

Equities

CVSI

US1266541028

Delayed OTC Markets Other stock markets 09:38:16 29/04/2024 pm IST			5-day change	1st Jan Change
0.0377 ^USD	+0.13%		-0.79%	+6.50%

28/03	Transcript : CV Sciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024
28/03	CV Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CV Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews	26/03
CV Sciences, Inc. acquired Cultured Foods Sp. z.o.o for $0.535 million.	12/12
CV Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
CV Sciences, Inc. Launches Reserve Sleep Gummies	05/23/05
CV Sciences, Inc. Seeks Acquisitions	14/23/14
CV Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/23/14
CV Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	16/23/16
CV Sciences Seeks M&A Opportunities	15/23/15
CV Sciences, Inc. Auditor Raises 'Going Concern' Doubt	30/23/30
CV Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	29/23/29
CV Sciences, Inc. Receives Formal Notice of Patent Issuance from Japan Patent Office for Formulations Containing Cannabidiol and Nicotine for Treating Smokeless Tobacco Addiction	23/23/23
CV Sciences, Inc. Launches New Line of THC-Free Gummies and Softgels	21/23/21
CV Sciences, Inc. Launches 30-Count of Popular +PlusCBD Reserve Collection Softgels	18/23/18
CV Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/22/14
CV Sciences, Inc. Appoints William McCorkle as Director	26/22/26
Sector Update: Financial	22/22/22
CV Sciences, Inc. Announces Launch of PlusCBD Reserve Collection Softgels	15/22/15
CV Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	15/22/15
CV Sciences, Inc. Appoints Jamie Corroon as Director	28/22/28

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages CV Sciences, Inc.

Equities

CVSI

US1266541028

Other languages

Filters